U.S., Dec. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07266688) titled 'Evaluation of Bactorinol(R) Nasal Spray in Adult Patients With Vasomotor Rhinitis' on Nov. 24.
Brief Summary: This study aims to evaluate the effectiveness and safety of Bactorinol(R) nasal spray, a medical device containing winterized Pistacia lentiscus oil, in adults with vasomotor rhinitis. Vasomotor rhinitis is a chronic condition characterized by nasal congestion, rhinorrhea, and impaired nasal airflow.
In this multicenter, prospective, randomized, controlled clinical trial, 100 adult participants will be assigned in a 1:1 ratio to receive either Bactorinol(R) nasal spray or isotonic saline solution for 20 consecutive days. The...